Vitamin D for Established Type 2 Diabetes (DDM2)
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 127 participants.
Also called NCT01736865
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 127 participants
- Registry
-
NCT01736865
-
- Other papers using this trial's data
- Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes
- Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01736865. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2019-01-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vitamin D for Established Type 2 Diabetes (DDM2)
- Acronym
- DDM2
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Cholecalciferol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Tufts Medical Center
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct01736865- Content hash
9319ade17963a42de66c2946fce238d560e2560a7e605ac56504dadfd6d5018d